Kuva Labs notifies Lisata it will not commence tender offer on June 1 as agreed; deal uncertain

LISATA THERAPEUTICS, INC.

On May 31, Kuva Labs told Lisata it will not start the tender offer on June 1 as previously agreed and amended.
No assurance on when or if the tender offer will commence; Kuva is still negotiating financing sources.
Merger Agreement signed March 6, 2026; amendment on May 29 extended start date to June 1.
Parent's failure to commence as agreed raises concern about deal completion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.